Project Description:
Open-label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (AeroquinTM) Versus Tobramycin Inhalation Solution (TIS) in Stable Cystic Fibrosis Patients
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A